Novel 4,5-dihydro-1H-pyrazole derivativeshaving CB1-antagonistic activity

Details for Australian Patent Application No. 2002333852 (hide)

Owner Solvay Pharmaceuticals B.V.

Inventors Van Stuivenberg, Herman, H.; Kruse, Cornelis, G.; Lange, Josephus, H.M.; Herremans, Arnoldus, H.J.; Tipker, Jacobus

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2002333852

PCT Number PCT/EP02/10433

PCT Pub. Number WO2003/026647

Priority 01203850.1 21.09.01 EP

Filing date 17 September 2002

Wipo publication date 7 April 2003

Acceptance publication date 13 July 2006

International Classifications

A61K 31/415 (2006.01) - 1,2-Diazoles

A61K 31/4155 (2006.01) - not condensed and containing further heterocyclic rings

C07D 231/06 (2006.01) Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings

C07D 401/06 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

Event Publications

13 February 2003 Complete Application Filed

  Priority application(s): 01203850.1 21.09.01 EP

26 June 2003 Application Open to Public Inspection

  Published as AU-B-2002333852

13 July 2006 Application Accepted

  Published as AU-B-2002333852

9 November 2006 Standard Patent Sealed

12 April 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002333853-4,5-dihydro-1H-pyrazole derivatives having potent CD1-antagonistic activity

2002333851-Combination of a PDE inhibitor and a leukotriene receptor antagonist